BioMed X in the Media
In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
Visit: Studying Depression at a Molecular Level
Studying Depression at a Molecular Level
Psychiatric Times
How do defective neuro-glia interactions contribute to depression? A recent study suggests that alterations in astrocyte metabolism is a major hallmark of depre …
Published: Mar 4, 2021
Visit: Digitization and AI at the Forefront
Digitization and AI at the Forefront
STARTUPCITY
“In the midst of every crisis, lies great opportunity.” Regarding the most important trends in biomedical research for 2021, this quote by Albert Einstein seems …
Published: Feb 18, 2021
Visit: Crossing the Border
Crossing the Border
the Medicine Maker
How to get macromolecules across the intestinal epithelial barrier
Published: Feb 10, 2021
Visit: J&J taps BioMed X for crowdsourced oral biologics delivery push
J&J taps BioMed X for crowdsourced oral biologics delivery push
FiercePharma
Johnson & Johnson has teamed up with BioMed X Institute to advance oral delivery of monoclonal antibodies and other biologics. The initiative will support the w …
Published: Feb 2, 2021
Visit: BioMed X begins research project for oral therapeutics delivery
BioMed X begins research project for oral therapeutics delivery
manufacturing Chemist
The collaboration with Janssen Research and Development was facilitated by Johnson & Johnson Innovation.
Published: Jan 26, 2021
Visit: El Instituto BioMed X inicia un nuevo proyecto de investigación sobre administración de fármacos en colaboración con Janssen
El Instituto BioMed X inicia un nuevo proyecto de investigación sobre administración de fármacos en colaboración con Janssen
FarmaIndustrial
El instituto de investigación independiente alemán BioMed X anuncia su nuevo proyecto de investigación con Janssen Research & Development, una de las compañías …
Published: Jan 26, 2021
Visit: BioMed X, Janssen Enter Oral Drug Delivery Alliance
BioMed X, Janssen Enter Oral Drug Delivery Alliance
ContractPharma
Aims to discover novel transport mechanisms which could be utilized for oral delivery of therapeutic modalities.
Published: Jan 26, 2021
Visit: BioMed X Launches Drug Delivery Research Project with Janssen
BioMed X Launches Drug Delivery Research Project with Janssen
BioPharm International
The project is aimed at discovering novel transport mechanisms in the human intestinal tract that could be used for oral delivery of diverse therapeutic modalit …
Published: Jan 26, 2021
Visit: Crowdsourcing and open innovation in drug discovery: recent contributions and future directions
Crowdsourcing and open innovation in drug discovery: recent contributions and future directions
Drug Discovery Today
The past decade has seen significant growth in the use of ‘crowdsourcing’ and open innovation approaches to engage ‘citizen scientists’ to perform novel scienti …
Published: Jan 15, 2021
Visit: BioMed X Institute completes first neuroscience research project with Boehringer Ingelheim
BioMed X Institute completes first neuroscience research project with Boehringer Ingelheim
SelectScience
Research Team BMP (Brain Microcircuits in Psychiatric Diseases) uncovered alterations in astrocyte metabolism as a major hallmark of depression
Published: Dec 14, 2020
Visit: Germany-based BioMed X Institute completed its first joint research project in neuroscience with Boehringer Ingelheim.
Germany-based BioMed X Institute completed its first joint research project in neuroscience with Boehringer Ingelheim.
BioSpace
Following completion of the project, the research has now transitioned to BI for additional development. The team has validated candidate genes in several biolo …
Published: Dec 10, 2020
Visit: The Biomed X Institute, of Heidelberg, Germany, said it completed its first joint research neuroscience project with Boehringer Ingelheim GmbH, of Ingelheim, Germany.
The Biomed X Institute, of Heidelberg, Germany, said it completed its first joint research neuroscience project with Boehringer Ingelheim GmbH, of Ingelheim, Germany.
BioWorld
The project launched in 2016 to uncover the contribution of astrocytes, a subtype of glial cells, to molecular phenotypes in depression.
Published: Dec 8, 2020